Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Sustainability Publication Digest: Combining innovation and sustainable development in the 3D printing manufacturing of drug delivery and testing devices

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. 

In a recent publication, Fratini et al. explored how additive manufacturing (3D printing) can align technological innovation with sustainability in the pharmaceutical and biomedical sectors. Drawing on global evidence, the authors demonstrated how additive manufacturing accelerates design cycles, reduces material waste, and supports patient-tailored treatment solutions. The review highlights 3D printing as a transformative driver for cost-effective and environmentally conscious healthcare technologies.

Access the full-text article here.